scispace - formally typeset
W

William E. Kraus

Researcher at Duke University

Publications -  625
Citations -  40583

William E. Kraus is an academic researcher from Duke University. The author has contributed to research in topics: Heart failure & Medicine. The author has an hindex of 93, co-authored 565 publications receiving 33692 citations. Previous affiliations of William E. Kraus include University of Texas Southwestern Medical Center & University of North Carolina at Chapel Hill.

Papers
More filters
Journal ArticleDOI

Health coaching and genetic risk testing in primary care: Randomized controlled trial.

TL;DR: Remote HC after SRA increased physical activity, which was sustained 6-months later, and Incorporating GRT into SRA warrants further exploration regarding the potential to leverage HC for weight loss in elevated T2D risk participants, and for depression in lower T2 D risk participants.
Journal ArticleDOI

Inflammation moderates the effects of lifestyle modification on neurocognition among individuals with resistant hypertension

TL;DR: This article explored the influence of inflammation on changes in cognition following lifestyle modification among individuals with resistant hypertension participating in the TRIUMPH clinical trial, and concluded that inflammatory profiles may help identify individuals more likely to improve executive functioning resulting from lifestyle modification.
Journal Article

Abstract 46: Legacy Effects of STRRIDE Exercise Training Programs on Cardiometabolic Health Observed Ten Years Later

TL;DR: STRRIDE Reunion observed group-specific legacy effects from a eight-month exercise training program, demonstrating the power and value for long-term CMH of even moderate term exercise interventions.
Journal Article

Abstract 12297: Relations between Baseline Physical Activity by Pedometer Counts and Future Cardiovascular Events in the NAVIGATOR Study

TL;DR: In this article, the effects of lifestyle (physical activity, nutrition) on defined clinical events were studied in clinical trials of diabetes (DM) or cardiovascular disease (CV) patients.